Overview

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA OOPD
Phase:
Phase 1
Details
Lead Sponsor:
Chris Goss
Collaborator:
Cystic Fibrosis Foundation
Treatments:
Gallium nitrate